Optical Particle Sizer (Particle Sizing Systems, Port Richey, FL, USA). Our results showed that the MPs have a wide distribution of particle size ranging from ~ 1.5 µm to 10 µm ( Figure S1 ).
The mean diameters of MPs before conjugation, MPs after VEGF antibody conjugation, and
MPs after VEGF protein conjugation were measured as 2.741 ± 0.012 µm, 2.788 ± 0.017 µm, and 2.787 ± 0.014 µm, respectively. The results were further confirmed by observing the MPs using a light microscope. by seeding hMSCs bilaterally on 600 µm decellularized porcine myocardium slices (dPMSs) as we previously described 1 . Briefly, 2 x 10 5 hMSCs were seeded on one side of dPMS and incubated in humidified cell culture incubator (37 °C; 5% CO2) for 4 h. After incubation, dPMS was flipped to receive cells on the other side at same cell density. The cells were incubated for another 4 h before adding 1 mL of complete cell growth medium for continuing culture. Next, the cells were maintained in humidified cell culture incubator (37 °C; 5% CO2) for 5 h, 10 h, 24 6 h, 72 h, and 120 h without replacing the growth medium. Subsequently, hMSC secretome was collected and centrifuged at 600 x g for 5 min at 4ºC to remove non-adherent cells. The hMSC secretome was either immediately used or stored at -20˚C until use. Following the same protocol, a negative control secretome sample was prepared using dPMS without incorporating cells. To validate our bioassay, we performed the following experiments. First, we measured the VEGF concentration of hMSC secretome with our immuno-disaggregation bioassay using antibodyconjugated MPs following the protocol described in the Materials and Methods section.
Secondly, we measured the VEGF concentration of hMSC secretome using commercially available human VEGF quantikine ELISA kit (R&D systems, Minneapolis, MN, USA)
following the manufacturer's recommendations. 
